This paper examines how a radical technological innovation affects alliance formation of firms and subsequent network structures. We use longitudinal data of interfirm R&D collaborations in the biopharmaceutical industry in which a new technological regime is established. Our findings suggest...

Investitionen in zukunftsfähige innovative Spitzentechnologien wie die Biotechnologie sind für ein hoch entwickeltes und rohstoffarmes Land wie Deutschland wichtig, um sich dauerhaft im internationalen Wettbewerb zu behaupten. Die Biotechnologie spielt als Schlüsseltechnologie in mehreren...

In the current paper we examine this industry along a number of dimensions and estimate its average financial risk. Specifically, we use Compustat and Center for Research in Securities Prices (CRSP) data from 1982 to 2005 for firms defined by the North American Industry Classification System...

Since 1991 the Commission's Eurobarometer surveys on biotechnology have played a vital role, providing a systematic, quantitative, comparable and dispassionate assessment of public perceptions across Europe. Surveys provide an indication of the distribution of opinions and attitudes in the...

Modern biomedical research is opening up many novel approaches to therapy. These include gene and cell therapy, immunotherapy, tissue engineering and regenerative medicine. These approaches offer hope for therapy of diseases which are currently untreatable, where life is at stake, and for...